Decade of translational research funding led to private-sector investment and new therapies

A new report has found that MRC funding schemes for translational research have boosted the UK’s life sciences industry since they were introduced in 2008. Over£530 million of new translational research funding since 2008 has led to MRC-linked spin-outs securing£1.1 billion in private sector investment and delivering health benefits, such as new gene therapies and medical devices.
Source: Medical Research Council General News - Category: Research Source Type: news